Dabur India's popular digestive candy, Hajmola, is currently being investigated by the Directorate General of GST Intelligence (DGGI) regarding its tax classification. The DGGI is examining whether Hajmola should be taxed at the 12% GST rate applicable to Ayurvedic medicines or the 18% rate for confectionery items. This revives a long-standing dispute, as the Supreme Court previously ruled in favour of Hajmola being an Ayurvedic medicine.
Dabur India's iconic digestive candy Hajmola has come under the radar of the Directorate General of GST Intelligence (DGGI). According to a report, the DGGI's Coimbatore zone is probing whether Hajmola should be taxed as anayurvedic medicine, attracting 12% GSTor reclassified as a confectionery item
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to
CCI PRO
for unlimited access
Why Upgrade to
CCI PRO?
-
No Ads
-
WhatsApp Broadcasts
-
Daily E-Newsletter
-
Unlimited News Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
Buy CCI PRO Now
Already a PRO member?
Login here
for an ad-free experience.
FAQ :
The Directorate General of GST Intelligence (DGGI) is investigating whether Hajmola should be taxed at 12% GST as an Ayurvedic medicine or 18% GST as a confectionery item.
Yes, in the pre-GST era, the Supreme Court ruled that Hajmola is an Ayurvedic medicine, not just a candy.
Dabur maintains that Hajmola is a proprietary Ayurvedic formulation and should be taxed at the lower 12% rate for Ayurvedic products.
Yes, Dabur also received an income tax reassessment order demanding Rs 110.33 crore for the financial year 2017-18.
Dabur is experiencing a slowdown in domestic demand, with expectations of flattish consolidated revenue growth for Q4 FY25 due to weak urban consumption and inflationary pressures.
Dabur is optimistic about its international markets, particularly in the MENA region, Egypt, and Bangladesh, which are projected to achieve robust double-digit growth.